2023 Chinese guideline for lipid management

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for ASCVD. Considering the increasing burden of ASCVD, lipid management is of the utmost importance. In recent years, research on blood lipids has made breakthroughs around the world, hence a revision of Chinese guideline for lipid management is imperative, especially since the target lipid levels in the general population vary in respect to the risk of ASCVD. The level of LDL-C, which can be regarded as appropriate in a population without frisk factors, can be considered abnormal in people at high risk of developing…

• SU
  Shandong University
• CS
  Chinese Society of Endocrinology
• QH
  Qilu Hospital of Shandong University
• CM
  Capital Medical University
• FU
  Fudan University
• CA
  Chinese Academy of Medical Sciences
• PU
  Peking University
• NU
  Nanjing University
• GH
  General Hospital of People’s Liberation Army
• CD
  Chinese Diabetes Society
• PU
  Peking University People's Hospital
• CP
  Chinese People’s Liberation Army
• RH
  Ruijin Hospital
• FH
  Fuwai Hospital, Chinese Academy of Medical Sciences
• BT
  Beijing Tian Tan Hospital, Capital Medical University